These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1068542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [10-years experience with myelobromol treatment of myelofibrosis].
    Klimova NF.
    Haematologia (Budap); 1977; 11(1-2):57-72. PubMed ID: 615089
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of chronic myeloid leukaemia with myelobromol.
    Petrányi G, Bobory J.
    Ther Hung; 1966; 14(4):136-40. PubMed ID: 5228102
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of dibromomannitol in the treatment of chronic myelogenous leukemia: report of 22 cases].
    Zhu XQ, Qian JW, Dai LY.
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):157-8, 197. PubMed ID: 3146485
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bone marrow transplantation in accelerated chronic granulocytic leukaemia using dibromomannitol-preconditioning instead of total-body irradiation.
    Kelemen E, Jánossa M, Triska E, Szalay F, Váradi A, Magyar T, Sellyei M.
    Leuk Res; 1985 Mar; 9(8):1009-15. PubMed ID: 3930887
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
    Silver RT, Mick R, Cooper R, Ellison RR, Levy R, Brunner K, Schwartz JM, Holland JF.
    Cancer; 1987 Oct 01; 60(7):1442-8. PubMed ID: 3113712
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
    Urasiński I, Mysik M.
    Wiad Lek; 1971 Jul 01; 24(3):271-4. PubMed ID: 5279032
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Recent developments in the treatment of chronic myeloid leukemia].
    Herrmann R.
    Med Klin; 1980 Aug 29; 75(18):645-9. PubMed ID: 6106883
    [No Abstract] [Full Text] [Related]

  • 17. [Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs].
    Kelemen E.
    Orv Hetil; 1983 Jan 02; 124(1):3-13. PubMed ID: 6402751
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Results and perspectives of therapy of chronic myelosis].
    Jaworkowsky L, Blumenthal R, Udris O, Sihle M, Terebkowa S.
    Z Gesamte Inn Med; 1983 Jun 01; 38(11):307-9. PubMed ID: 6351448
    [Abstract] [Full Text] [Related]

  • 20. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
    Horváth IP, Somfai-Relle S, Hegedüs L, Jarman M.
    Eur J Cancer Clin Oncol; 1982 Jun 01; 18(6):573-7. PubMed ID: 6811281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.